Inhibitory Substances Sample Clauses

The Inhibitory Substances clause defines restrictions or requirements regarding the presence of substances that could interfere with a process, product, or system. Typically, this clause specifies which substances are considered inhibitory, sets acceptable limits, and outlines testing or reporting obligations for parties involved. For example, in a manufacturing or laboratory context, it may prohibit certain chemicals that could compromise product quality or safety. The core function of this clause is to ensure the integrity and reliability of outcomes by preventing contamination or interference from unwanted substances.
Inhibitory Substances. If contamination is suspected, you must contact Milk Department immediately and prior to collection. Our field team will manage the impact of the incident to ensure all contractual obligations are met. It is compulsory that all milk tested comply with the following.
View SourceView Similar (16)
Inhibitory Substances. All milk tankers are tested for inhibitory substances before milk is unloaded into the factory (Section 4.6). If a milk tanker tests positive for inhibitory substances, then a vat sample from each farm contributing to the load will be tested in order to determine the offending farm(s). This procedure is known as ‘trace-back’ for inhibitory substances. Individual supplier samples are randomly tested at least twice a month for the presence of inhibitory substances. SDA may increase testing frequency, as necessary.
View SourceView Similar (2)
Inhibitory Substances. The presence of inhibitory substances in milk and its products can cause severe risks to human health and affect the manufacturing properties of that milk. Prohibited inhibitory substances include, but are not limited to, antibiotics and chemical residues (including dairy detergents) such as Quaternary Ammonium Compounds (QACs) and Nonylphenol Ethoxylates (NPEs). All milk tankers, including those operated by third parties, are tested for inhibitory substances prior to unloading. Suppliers are encouraged to notify SDA of any inhibitory substance issues as they arise (refer Section 4.8). Where an inhibitory substance is detected and subsequently confirmed but SDA was not notified in advance of collection: • SDA will determine which farm(s) supplied the milk, and the relevant supplier(s) must deliver a vat sample prior to their next collection to a designated site for testing. Collection will only recommence once a negative test result is obtained; and • milk quality discounts will apply (refer Table 1, Section 4.2 and Table 7, Section 5.3 of this Handbook). Suppliers with non-notified inhibitory substance detections, or identified high-risk practices, may have their audit and/or random inhibitory substance test frequency increased. Where any farm has two non-notified inhibitory substance detections in a month or three non-notified inhibitory substance incidents within a rolling 12-month period, this will be considered a material breach of your Milk Supply Agreement. SDA may permanently cease collection by written notice to you.
View SourceView Similar (2)
Inhibitory Substances. No driver or Attendant shall use or be under the influence of alcohol, narcotics, illegal drugs or drugs that impair ability to perform while on duty. Furthermore, all drivers and Attendants must pass a drug test prior to employment and shall be subject to drug tests randomly and upon suspicion by a Transportation Provider or Broker. A drug test will also be required when a driver is involved in any motor vehicle accident.
View Source

Related to Inhibitory Substances

  • Chemical Substances Supplier warrants that: (i) each chemical substance contained in Products is on the inventory of chemical substances compiled and published by the Environmental Protection Agency pursuant to the Toxic Substances Control Act and (ii) all Material Safety Data Sheets required to be provided by Supplier for Products shall be provided to DXC prior to shipment of the Products and shall be complete and accurate.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Dangerous Materials Tenant shall not keep or have on the Premises any article or thing of a dangerous, flammable, or explosive character that might substantially increase the danger of fire on the Premises, or that might be considered hazardous by a responsible insurance company, unless the prior written consent of Landlord is obtained and proof of adequate insurance protection is provided by Tenant to Landlord.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Vaccination and Inoculation ‌ (a) The Employer agrees to take all reasonable precautions to limit the spread of infectious diseases among employees, including in-service seminars for employees. Where the Employer or Occupational Health and Safety Committee identifies high risk areas which expose employees to infectious or communicable diseases for which there are protective immunizations available, such immunizations shall be provided at no cost to the employee. The Committee may consult with the Medical Health Officer. Where the Medical Health Officer identifies such a risk, the immunization shall also be provided at no cost. The Employer shall provide Hepatitis B vaccine, free of charge, to those employees who may be exposed to bodily fluids or other sources of infection. (b) An employee may be required by the Employer, at the request of and at the expense of the Employer, to take a medical examination by a physician of the employee's choice. Employees may be required to take skin tests, x-ray examination, vaccination, and other immunization (with the exception of a rubella vaccination when the employee is of the opinion that a pregnancy is possible), unless the employee's physician has advised in writing that such a procedure may have an adverse effect on the employee's health.